The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

Intellia Therapeutics has paused dosing in its Phase 3 MAGNITUDE trials after a patient experienced severe liver toxicity, as ...

A study volunteer receiving Intellia’s transthyretin amyloidosis treatment was hospitalized due to severe signs of liver ...

Intellia Therapeutics (NASDAQ:NTLA) shares plummeted 50% on Monday after the company announced a temporary halt to patient dosing and screening in its Phase 3 trials of nex-z, citing a serious ...

Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company has ...

During a weekend where the world went Battlefield 6 mad, it’s fair to realise that not everybody likes hunting around for cheap kills in an FPS shooter. Also arriving was an extension to the anime hit ...

The Homestead feature in Blue Protocol is a great way to exercise freedom with customizable housing, but it's also useful (Image via A-Plus) All characters in Blue Protocol can take advantage of the ...

Blue Protocol has a lot of freebies you can get through just watching streams (Image via A Plus) You can get a lot of free rewards consistently from Blue Protocol Star Resonance Twitch drops. By ...

CRISPR Therapeutics AG CRSP shares soared 8.7% in the last trading session to close at $76.78. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...